Lucid Group stock price had a difficult performance this year as it continued falling due to major headwinds. It has dropped ...
In a report released today, Michael Matson from Needham maintained a Buy rating on Lucid Diagnostics (LUCD – Research Report), with a price target of $2.50. Michael Matson has given his Buy rating due ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback